America’s drug-price strategy could hit Swiss health-insurance premiums
Efforts to cut American drug prices could cost Swiss health-insurance premium payers hundreds of millions of francs a year, a new study finds. Drug prices in Switzerland are among the world’s highest. In America, they are higher still. The American government wants pharmaceutical companies to charge less for new medicines. For firms such as Roche […]